Young Adults Face Steep Increase of Colorectal Cancer Risk
New study shows increased risk of colorectal cancer among young adults as risk among older adults declines.
PUBLISHED: MARCH 03, 2017
The authors noted that age-specific CRC risk of those born around 1990 has escalated back to the level of those born around 1890.They suggest that these trends represent changes in exposure to risk factors such as excess body weight, high consumption of processed meat and alcohol, low levels of physical activity, low levels of fiber consumption and cigarette smoking. There has been a parallel rise of the obesity epidemic, which shares behaviors that independently increase CRC risk. Additionally, a study has shown that a Western-style, high-fat, low-fiber diet initiates inflammation and proliferation in the colonic mucosa — where nutrients, fats and proteins are absorbed from the foods we eat — within two weeks.
While detection of preclinical disease could be because of rising colonoscopy utilization, rates have risen at a similar magnitude for both early- and advanced-stage diseases which is inconsistent with a screening effect.
Talk about this article with other patients, caregivers, and advocates in the Colorectal Cancer CURE discussion group.
Generally, health insurance covers the cost of genetic testing recommended by a physician. However, some patients who had BRCA testing in the past have had trouble getting reimbursed for a follow-up panel test. The outof- pocket cost for a single panel test can be up to $5,000, although lower-cost tests are available.
When treated for cancer, young patients don’t always get the information they need from doctors.
Socioeconomic status, race and other disparities among patients can affect cancer treatments and outcomes. Researchers are working to change that.
Renata Marie Vestevich, founder and developer of Essential Eyebrow Solution (EES), discusses how this topical solution may be able to help patients keep their eyebrow hair while undergoing chemotherapy.
Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.
Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.